| Literature DB >> 19138422 |
Ina C Ennker1, Anita Malkoc, Detlef Pietrowski, Peter M Vogt, Juergen Ennker, Alexander Albert.
Abstract
Deep sternal infections, also known as poststernotomy mediastinitis, are a rare but often fatal complication in cardiac surgery. They are a cause of increased morbidity and mortality and have a significant socioeconomic aspect concerning the health system. Negative pressure wound therapy (NPWT) followed by muscular pectoralis plasty is a quite new technique for the treatment of mediastinitis after sternotomy. Although it could be demonstrated that this technique is at least as safe and reliable as other techniques for the therapy of deep sternal infections, complications are not absent. We report about our experiences and complications using this therapy in a set of 54 patients out of 3668 patients undergoing cardiac surgery in our institution between January 2005 and April 2007.Entities:
Mesh:
Year: 2009 PMID: 19138422 PMCID: PMC3225867 DOI: 10.1186/1749-8090-4-5
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Classification of mediastinitis in patients undergoing cardiac surgery.
| Class | Description |
|---|---|
| Type I | Mediastinitis presenting within 2 weeks after operation in the absence of risk factors |
| Type II | Mediastinitis presenting at 2 to 6 weeks after operation in the absence of risk factors |
| Type IIIA | Mediastinitis type I in the presence of one or more risk factors |
| Type IIIB | Mediastinitis type II in the presence of one or more risk factors |
| Type IVA | Mediastinitis type I, II, or III after one failed therapeutic trial |
| Type IVB | Mediastinitis type I, II, or III after more than one failed therapeutic trial |
| Type V | Mediastinitis presenting for the first time more than 6 weeks after operation |
According to El Oakley and Wright [8] mediastinitis is defined as wound infection associated with sternal osteomyelitis with or without infected retrosternal space. Incremental risk factors for mediastinitis are diabetes, obesity, and the requirement of immunosuppressive agents. Failed therapeutic trial includes any surgical intervention with intent to treat mediastinitis.
Figure 1Patient after bypass operation and deep sternal wound infection treated in our hospital. The patient received NPWT before surgical approach for cleaning of the wound.
Figure 2The figure shows the wound prior to refixation with pectoralis muscle already prepared for coverage of the sternum (a) and with the pectoralis plasty in place.
Figure 3The figure presents the complete closure of the wound after NPWT therapy and pectoralis plasty.
Preoperative patient characteristics of patients developing DSI and control group
| Patient characteristics, preoperative | Mediastinitis group | Control group | P-value of univariate comparisons |
|---|---|---|---|
| Male gender | 43 (81%) | 3189 (69%) | < 0,05 |
| Age [years] | 67,9 ± 1,4 | 67,8 ± 0,15 | n.s. |
| Body height [cm] | 168,7 ± 1,2 | 170 ± 0,12 | n.s. |
| Body weight [kg] | 88,9 ± 2,1 | 80,7 ± 0,2 | < 0,001 |
| Body-mass-index | 31,3 ± 0,6 | 27,9 ± 0,07 | < 0,001 |
| Diabetes, oral | 14 (26%) | 851 (18%) | < 0,05 |
| Diabetes, insulin-dependent | 12 (22%) | 549 (12%) | < 0,05 |
| Ejection fraction [%] | 54 ± 3,7 | 58 ± 0,4 | n.s. |
| Hemoglobin, preoperative [g/dl] | 13,5 ± 0,2 | 13,3 ± 0,02 | n.s. |
| Hematocrit, preoperative [%] | 40,3 ± 0,7 | 39,4 ± 0,1 | n.s. |
| Leukocytes, preoperative [k/UL] | 8,4 ± 0,7 | 7,8 ± 0,1 | n.s. |
| Serum creatinine, preoperative [mg/dl] | 1,2 ± 0,1 | 1,2 ± 0,01 | n.s. |
| Creatinine kinase MB, preoperative [U/l] | 21 ± 16,1 | 28,7 ± 2,0 | n.s. |
| Chronic obstructive pulmonary disease | 20 (38%) | 918 (20%) | <0,01 |
| Reduced ejection fraction | 24 (44%) | 1620 (34%) | P = 0,11 |
| EuroSCORE | 5,7 ± 0,4 | 5,9 ± 0,05 | n.s. |
| CRP, preoperative [mg/l] | 16,5 ± 3,9 | 11,4 ± 0,4 | P = 0.19 |
According to El Oakley and Wright [8] mediastinitis is defined as wound infection associated with sternal osteomyelitis with or without infected retrosternal space. Incremental risk factors for mediastinitis are diabetes, obesity, and the requirement of immunosuppressive agents. Failed therapeutic trial includes any surgical intervention with intent to treat mediastinitis.
Intra- and postoperative patient characteristics of patients developing DSI and control group
| Indicators of course after major cardiac surgery | Mediastinitis group | Control group | P-value of univariate comparisons |
|---|---|---|---|
| Double internal mammary arteries | 13 (24%) | 1112 (23%) | n.s. |
| Pump time [min] | 94,5 ± 7,3 | 81,2 ± 0,8 | = 0,06 |
| Aortic clamp time | 68 ± 4,9 | 57 ± 0,51 | <0,05 |
| Operation time | 207 ± 8,1 | 192,2 ± 0,9 | = 0,06 |
| Postoperative stay [days] | 33 ± 1 | 7,0 ± 0,1 | < 0,001 |
| Atrial fibrillation, postoperative | 30 (56%) | 2042 (43%) | P = 0.06 |
| Reintubation | 19 (35%) | 193 (4%) | < 0,001 |
| Pleural effusions | 24 (44%) | 1998 (42%) | n.s. |
| Rethorakotomy | 7 (13%) | 113 (2,3%) | < 0,001 |
| Hemoglobin, 6 h postoperative [g/dl] | 10,5 ± 0,2 | 10,4 ± 0,16 | n.s. |
| Hemoglobin, discharge [g/dl] | 10,5 ± 0,2 | 11,2 ± 0,02 | < 0,001 |
| Erythrocytes, minimum during stay [g/dl] | 2,8 ± 0,05 | 3,0 ± 0,01 | < 0,001 |
| Leukocytes, 6h postoperative [k/UL] | 10,7 ± 0,8 | 10,0 ± 0,1 | n.s. |
| Leukocytes, maximum postoperative [k/UL] | 17,6 ± 1,1 | 14,3 ± 0,1 | < 0,01 |
| Serumcreatinine, postoperative [mg/dl] | 2,4 ± 0,15 | 1,6 ± 0,02 | < 0,001 |
| Higher serum sodium postoperative [mmol/l] | 145,9 ± 0,5 | 143,7 ± 0,05 | < 0,001 |
Multivariate risk factors for postoperative mediastinitis
| Term | Estimate | Std Error | P-value | Odds Ratio |
|---|---|---|---|---|
| Intercept | 6,01 | 1,48 | < 0,001 | |
| Chronic obstructive pulmonary disease | 0,35 | 0,15 | 0,02 | 2,01 |
| Rethoracotomy (other than wound infection) | 0,30 | 0,25 | 0,23 | 1,82 |
| Reintubation | 1,14 | 0,17 | < 0,001 | 9,79 |
| Higher Body mass index | -0,14 | 0,02 | < 0,001 | 0,00 |
| More red cell package postop | -0,03 | 0,02 | 0,19 | 0,10 |
| Lower haemoglobin at discharge | 0,19 | 0,11 | 0,09 | 7,15 |
| Male gender | -0,45 | 0,19 | 0,02 | 0,41 |
| Higher creatinine postoperative | -0,16 | 0,09 | 0,08 | 0,14 |
No significant differences between types of operation were observed (ANOVA)
| Type of Surgery | N | Expected risk for mediastinits [%] | Observed incidence of mediasitnitis [%] | Observed/Expected |
|---|---|---|---|---|
| On-PCAB | 1671 | 1,1 | 1,6 | 1,4 |
| O(ff)-PCAB | 917 | 1,0 | 0,4 | 0,4 |
| Valve&CABG | 710 | 1,3 | 1,7 | 1,3 |
| Aortic surgery | 229 | 1,2 | 0,4 | 0,1 |
| Isolated Valves | 2582 | 1,1 | 1,2 | 1,0 |
| Double valves | 76 | 1,1 | 1,3 | 4,2 |
| Re-do valves | 106 | 1,5 | 0,9 | 0,2 |
| Miscellaneous | 174 | 1,1 | 1,7 | 1,7 |
No significant differences between the surgeons were observed (ANOVA)
| Surgeons | N | Expected risk for mediastinits [%] | Observed incidence of mediasitnitis [%] | Observed/Expected |
|---|---|---|---|---|
| Surg. A | 331 | 1,2 | 1,2 | 1,0 |
| Surg. B | 294 | 1,0 | 1,7 | 1,6 |
| Surg. C | 746 | 1,1 | 0,7 | 0,6 |
| Surg. D | 685 | 1,3 | 1,3 | 1,0 |
| Surg. E | 205 | 1,4 | 0,0 | 0,0 |
| Surg. F | 921 | 1,0 | 1,0 | 0,9 |
| Surg. G | 576 | 1,2 | 1,4 | 1,1 |
| Trainees | 1031 | 1,1 | 1,2 | 1,1 |
Complications occurred during NPWT
| Complication | Number/ | Percent |
|---|---|---|
| Instable sternum | 1 | 1.9 |
| Infection other than Mediastinitis | 2 | 3.7 |
| Respiratory failure | 4 | 7.4 |
| Atrial fibrillation | 5 | 9.3 |
| Re-Thoracotomy | 1 | 1.9 |
| Rupture of the right ventricle | 1 | 1.9 |
| No complication | 40 | 74.1 |